Reily Genomics Inc. has raised $15 million in Series B funding, according to a regulatory filing. Kleiner Perkins Caufield & Byers was joined by return backer Mohr Davidow Ventures. Brook Byers of Kleiner is joining MDV's Michael Goldberg on the board of directors.
The Palo Alto, Calif.-based startup integrates diagnostics with therapeutics to identify the right patients for the right medication at the right dose at the right time. www.rileygenomics.com